Cargando…
Emerging Therapies for Hepatocellular Carcinoma (HCC)
SIMPLE SUMMARY: Primary liver cancer, also known as Hepatocellular carcinoma (HCC), is considered to be a major global health challenge. Due to delays in diagnosis at early asymptomatic stages, HCC reaches a severe aggressive stage, thereby having a significant negative impact on patient survival. I...
Autores principales: | Chakraborty, Eesha, Sarkar, Devanand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179883/ https://www.ncbi.nlm.nih.gov/pubmed/35681776 http://dx.doi.org/10.3390/cancers14112798 |
Ejemplares similares
-
Current Status of Gene Therapy in Hepatocellular Carcinoma
por: Reghupaty, Saranya Chidambaranathan, et al.
Publicado: (2019) -
Non-Coding RNAs: Regulating Disease Progression and Therapy Resistance in Hepatocellular Carcinoma
por: Manna, Debashri, et al.
Publicado: (2020) -
Macrophage metabolism, phenotype, function, and therapy in hepatocellular carcinoma (HCC)
por: Huang, Jingquan, et al.
Publicado: (2023) -
Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression
por: Kotsari, Maria, et al.
Publicado: (2023) -
Advances in Immunotherapy for Hepatocellular Carcinoma (HCC)
por: Bicer, Fuat, et al.
Publicado: (2023)